Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Novo Nordisk A/S (NVO) vs Trade Desk Inc (TTD) Price & Performance

Novo Nordisk A/STrade
Trade Desk IncTrade

Price performance (Past 24H)

Key statistics

Novo Nordisk A/S vs Trade Desk Inc — how do they compare? Novo Nordisk A/S trades at $45.93 (market cap $207.85B), while Trade Desk Inc trades at $13.54 (market cap $6.37B). The key difference: Novo Nordisk A/S is far larger — about 32.6× Trade Desk Inc's market cap, and Novo Nordisk A/S pays a 3.81% dividend while Trade Desk Inc pays none. Which is the better fit depends on your goals.

NVOTTD
Market Cap
$207.85B$6.37B
Sector
HealthTechnology
52-Week High
$63.98$55.36
52-Week Low
$35.29$13.39
Enterprise Value
$222.55B$5.32B
Dividend Yield
3.81%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Novo Nordisk A/S

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Read more on NVO

About Trade Desk Inc

The Trade Desk Inc is engaged in providing a technology platform for ad buyers. Through its cloud-based platform ad buyers can create, manage, and optimize data-driven digital advertising campaigns across ad formats and channels, including display, video, audio, in-app, native and social, on a multitude of devices. Its products include Data Management Platform, Cross-Device Targeting, Video Advertising, Mobile Advertising, and others.

Read more on TTD